Targeting adhesion to the vascular niche to improve therapy for acute myeloid leukemia
Niche hijack by malignant cells is considered to be a prominent cause of disease relapse. Barbier and colleagues uncover (E)-selectin as a novel mediator of malignant cell survival and regeneration which, upon blockade, has the potential to significantly improve therapeutic outcomes.
Saved in:
Main Authors: | Myriam L. R. Haltalli, Cristina Lo Celso |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/7fb30f4555cf4ea288f251cabb681d85 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance
by: Valerie Barbier, et al.
Published: (2020) -
Targeting CD38 in acute myeloid leukemia interferes with leukemia trafficking and induces phagocytosis
by: Meike Farber, et al.
Published: (2021) -
Adhesion Molecules Involved in Stem Cell Niche Retention During Normal Haematopoiesis and in Acute Myeloid Leukaemia
by: Julien M. P. Grenier, et al.
Published: (2021) -
Global Identification of EVI1 Target Genes in Acute Myeloid Leukemia.
by: Carolyn Glass, et al.
Published: (2013) -
Circular RNAs in acute myeloid leukemia
by: Vijendra Singh, et al.
Published: (2021)